Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,179 | 10,693 | 10,570 | 12,411 | 14,525 |
| Receivables | 33 | 39 | 40 | 44 | 70 |
| TOTAL | $10,725 | $11,575 | $11,150 | $13,564 | $15,748 |
| Non-Current Assets | |||||
| PPE Net | 258 | 275 | 318 | 328 | 289 |
| Other Non-Current Assets | 458 | 534 | 0 | 0 | 0 |
| TOTAL | $716 | $809 | $318 | $328 | $289 |
| Total Assets | $11,441 | $12,384 | $11,469 | $13,892 | $16,038 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,061 | 2,432 | 1,409 | 1,714 | 2,322 |
| Other current liabilities | N/A | 713 | 763 | 768 | 719 |
| TOTAL | $3,340 | $3,414 | $2,171 | $2,483 | $3,041 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,269 | 4,682 | 4,517 | 4,483 | 4,497 |
| TOTAL | $5,269 | $4,682 | $4,517 | $4,483 | $4,497 |
| Total Liabilities | $8,609 | $8,096 | $6,689 | $6,966 | $7,538 |
| Shareholders' Equity | |||||
| Common Shares | 218,786 | 217,740 | 220,026 | 217,176 | 218,906 |
| Retained earnings | -240,517 | -238,044 | -240,309 | -234,721 | -235,079 |
| Other shareholders' equity | 3,066 | 3,134 | 3,260 | 3,120 | 3,198 |
| TOTAL | $2,832 | $4,288 | $4,780 | $6,926 | $8,499 |
| Total Liabilities And Equity | $11,441 | $12,384 | $11,469 | $13,892 | $16,037 |